Hee-Jeong Hwang

Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia.

Dong-Wook Kim, Soo-hyun Kim, Sung‐Eun Lee, 2015, Leukemia research.

Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies

Kyung-Hee Kim, B. Yoo, S. Woo, 2021, EPMA Journal.

BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia

Dong-Wook Kim, Soo-hyun Kim, Sung‐Eun Lee, 2016, The Korean journal of internal medicine.

Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy

Dong-Wook Kim, Soo-hyun Kim, Sung‐Eun Lee, 2018, Leukemia & lymphoma.